BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 28196140)

  • 1. Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
    Gao X; Hicks KC; Neumann P; Patel TB
    PLoS One; 2017; 12(2):e0171616. PubMed ID: 28196140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.
    Hicks KC; Patel TB
    J Biol Chem; 2016 Aug; 291(32):16787-801. PubMed ID: 27281823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.
    Farrall AL; Whitelaw ML
    Oncogene; 2009 Oct; 28(41):3671-80. PubMed ID: 19668230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
    Lin J; Qin X; Zhu Z; Mu J; Zhu L; Wu K; Jiao H; Xu X; Ye Q
    IUBMB Life; 2012 Nov; 64(11):921-30. PubMed ID: 23086815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer.
    Ordóñez-Morán P; Irmisch A; Barbáchano A; Chicote I; Tenbaum S; Landolfi S; Tabernero J; Huelsken J; Muñoz A; Pálmer HG
    Oncogene; 2014 Apr; 33(15):1975-85. PubMed ID: 23624922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.
    Steunou AL; Ducoux-Petit M; Lazar I; Monsarrat B; Erard M; Muller C; Clottes E; Burlet-Schiltz O; Nieto L
    Mol Cell Proteomics; 2013 Mar; 12(3):736-48. PubMed ID: 23275444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.
    Tsai YP; Chen HF; Chen SY; Cheng WC; Wang HW; Shen ZJ; Song C; Teng SC; He C; Wu KJ
    Genome Biol; 2014 Dec; 15(12):513. PubMed ID: 25517638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration.
    Yang X; Yang S; Wang C; Kuang S
    J Biol Chem; 2017 Apr; 292(14):5981-5991. PubMed ID: 28232488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection.
    Aprelikova O; Wood M; Tackett S; Chandramouli GV; Barrett JC
    Cancer Res; 2006 Jun; 66(11):5641-7. PubMed ID: 16740701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.
    Ahmad A; Ahmad S; Glover L; Miller SM; Shannon JM; Guo X; Franklin WA; Bridges JP; Schaack JB; Colgan SP; White CW
    Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10684-9. PubMed ID: 19541651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione peroxidase 8 is transcriptionally regulated by HIFα and modulates growth factor signaling in HeLa cells.
    Bosello-Travain V; Forman HJ; Roveri A; Toppo S; Ursini F; Venerando R; Warnecke C; Zaccarin M; Maiorino M
    Free Radic Biol Med; 2015 Apr; 81():58-68. PubMed ID: 25557012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer.
    Cui J; Duan B; Zhao X; Chen Y; Sun S; Deng W; Zhang Y; Du J; Chen Y; Gu L
    Tumour Biol; 2016 Oct; 37(10):13455-13467. PubMed ID: 27465550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of an intronic HIF-2α binding site suppresses hypoxia-induced WT1 expression.
    Krueger K; Catanese L; Sciesielski LK; Kirschner KM; Scholz H
    Biochim Biophys Acta Gene Regul Mech; 2019 Jan; 1862(1):71-83. PubMed ID: 30468780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers.
    Stuckel AJ; Zeng S; Lyu Z; Zhang W; Zhang X; Dougherty U; Mustafi R; Zhang Q; Joshi T; Bissonnette M; Choudhury SR; Khare S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene.
    Martens LK; Kirschner KM; Warnecke C; Scholz H
    J Biol Chem; 2007 May; 282(19):14379-88. PubMed ID: 17374610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.